Bayer backs out of Atara cell therapy deal
Dive Brief:
Bayer plans stop developing cancer cell therapies with Atara Biotherapeutics, informing the California biotech company that it will terminate a researc...
From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
Advertisement